T. Rowe Price Investment Management, Inc. Ionis Pharmaceuticals Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $163 Billion
- Q1 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 13,317,112 shares of IONS stock, worth $614 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
13,317,112
Previous 13,201,453
0.88%
Holding current value
$614 Million
Previous $668 Million
13.56%
% of portfolio
0.35%
Previous 0.43%
Shares
7 transactions
Others Institutions Holding IONS
# of Institutions
398Shares Held
122MCall Options Held
854KPut Options Held
464K-
Vanguard Group Inc Valley Forge, PA13.4MShares$619 Million0.01% of portfolio
-
Black Rock Inc. New York, NY9.77MShares$450 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.3MShares$383 Million5.64% of portfolio
-
Wellington Management Group LLP Boston, MA5.7MShares$263 Million0.04% of portfolio
-
Clearbridge Investments, LLC New York, NY4.47MShares$206 Million0.16% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6.54B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...